Related Experiment Video

Updated: Aug 16, 2025

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.5K

Emerging role of Protein Kinase CK2 in Tumor immunity

Leichong Chen1, Sijia Zhang1, Qianwen Li1

  • 1Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Frontiers in Oncology
|December 19, 2022
PubMed

Insights

Protein kinase CK2 (CK2) is vital in cancer development and impacts tumor immunity. This review details CK2

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Protein kinase CK2 (CK2) is a ubiquitous enzyme involved in numerous cellular processes.
  • CK2 overexpression is linked to various cancers, tumor progression, and poor prognosis.
  • The role of CK2 in tumor immunity, particularly within the tumor microenvironment (TME), requires comprehensive elucidation.

Purpose of the Study:

  • To systematically review the multifaceted roles of CK2 in regulating immune cells within the TME.
  • To elucidate the underlying molecular mechanisms by which CK2 influences innate and adaptive immunity in cancer.
  • To provide insights into novel therapeutic strategies combining CK2 inhibition with immunotherapy.

Main Methods:

  • Systematic literature review focusing on studies investigating CK2 and its interaction with immune cells in the TME.
  • Analysis of existing research on CK2's signaling pathways and substrate interactions relevant to immune modulation.
  • Integration of findings from preclinical and clinical studies on CK2 inhibitors and immunotherapy.

Main Results:

  • CK2 significantly impacts various immune cell populations within the TME, affecting both innate and adaptive immune responses.
  • Specific molecular mechanisms detailing CK2's influence on immune cell function and TME composition are identified.
  • Evidence suggests CK2 plays a dual role, potentially promoting or suppressing anti-tumor immunity depending on the context.

Conclusions:

  • CK2 is a critical regulator of tumor immunity, influencing diverse immune cell types in the TME.
  • Understanding CK2's mechanisms in the TME is crucial for developing effective cancer immunotherapies.
  • Targeting CK2 may represent a promising strategy to enhance the efficacy of current immunotherapeutic approaches.
Keywords:
PD-L1protein kinase CK2signal pathwaytumor immunity and immunotherapytumor microenvirenment

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.0K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

592

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K